ExploreWatchlistsPricing
  1. JP-listed companies
  2. RaQualia Pharma Inc.
  3. Financials
  4. Income before tax

RaQualia Pharma Inc. (4579)

Market cap
¥22.3B
P/E ratio
-331.8x
Rakuoria Drug Discovery develops new pharmaceutical compounds through early-stage research and clinical trials, then licenses them to major pharmaceutical companies for revenue.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Dec 31, 2025438-221.14%
Dec 31, 2024-362+23.21%
Dec 31, 2023-293-132.44%
Dec 31, 2022904+4.68%
Dec 31, 2021864-263.73%
Dec 31, 2020-528-2544.77%
Dec 31, 201922-102.03%
Dec 31, 2018-1,065+1221.57%
Dec 31, 2017-81-88.82%
Dec 31, 2016-721-59.85%
Dec 31, 2015-1,795-7.57%
Dec 31, 2014-1,942+6.74%
Dec 31, 2013-1,820-37.06%
Dec 31, 2012-2,891+51.66%
Dec 31, 2011-1,906

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat